Since angiotensin II type 1 receptor inhibitors prevent angiotensin II-mediated microtubular reorganization, vascular failure initiated by angiotensin II at least in part could arise from the endothelial dysfunction associated with microtubule restructuring (Hashimoto-Komatsu et al., 2011). The gene discussed is AGT; the disease is endothelial dysfunction.